Robinson Test Bank
Chapter 1. The Role of the Nurse Practitioner as Prescribed.
Multiple Choice
Identify the choice that best completes the statement or answers the question.
1. Nurse practitioner prescriptive authority is regulated by:
1. The National Council of State Boards of Nursing
2. The U.S. Drug Enforcement Administration
3. The State Board of Nursing for each state
4. The State Board of Pharmacy
2. kThe kbenefits kto kthe kpatient kof khaving kan kAdvanced kPractice kRegistered kNurse k(APRN)
kprescriber kinclude:
1. Nurses kknow kmore kabout kPharmacology kthan kother kprescribers kbecause kthey
ktake kit kboth kin ktheir kbasic knursing kprogram kand kin ktheir kAPRN kprogram.
2. Nurses kcare kfor kthe kpatient kfrom ka kholistic kapproach kand kinclude kthe
kpatient kin kdecision kmaking kregarding ktheir kcare.
3. APRNs kare kless klikely kto kprescribe knarcotics kand kother kcontrolled ksubstances.
4. APRNs kare kable kto kprescribe kindependently kin kall kstates, kwhereas ka
kphysician’s kassistant kneeds kto khave ka kphysician ksupervising ktheir
kpractice.
k 3. kClinical kjudgment kin kprescribing k includes:
1. Factoring kin kthe kcost kto kthe kpatient kof kthe kmedication kprescribed
2. Always kprescribing kthe knewest kmedication kavailable kfor kthe kdisease kprocess
3. Handing kout kdrug ksamples kto kpoor kpatients
4. Prescribing kall kgeneric kmedications kto kcut kcosts
k 4. kCriteria kfor kchoosing kan keffective kdrug kfor ka kdisorder k include:
1. Asking kthe kpatient kwhat kdrug kthey kthink kwould kwork kbest kfor kthem
2. Consulting knationally krecognized kguidelines kfor kdisease kmanagement
3. Prescribing kmedications kthat kare kavailable kas ksamples kbefore kwriting ka kprescription
4. Following kU.S. kDrug kEnforcement kAdministration kguidelines kfor kprescribing
k 5. kNurse kpractitioner kpractice kmay kthrive kunder khealth-care kreform kbecause k of:
1. The kdemonstrated kability kof knurse kpractitioners kto kcontrol kcosts kand kimprove
kpatient koutcomes
2. The kfact kthat knurse kpractitioners kwill kbe kable kto kpractice kindependently
3. The kfact kthat knurse kpractitioners kwill khave kfull kreimbursement kunder
khealth- kcare kreform
4. The kability kto kshift kaccountability kfor kMedicaid kto kthe kstate klevel
,Pharmacotherapeutics for Advanced Practice Nurse Prescribers, 5th edition Woo
Robinson Test Bank
Chapter k1. kThe kRole kof kthe kNurse kPractitioner kas kPrescribed.
Chapter k1. kThe kRole kof kthe kNurse kPractitioner kas
kPrescriber kAnswer kSection
MULTIPLE kCHOICE
1. ANS: k k3 PTS: k 1
2. ANS: k k2 PTS: k 1
3. ANS: k k1 PTS: k 1
4. ANS: k k2 PTS: k 1
5. ANS: k k1 PTS: k 1
,Pharmacotherapeutics for Advanced Practice Nurse Prescribers, 5th edition Woo
Robinson Test Bank
Chapter k1. kThe kRole kof kthe kNurse kPractitioner kas kPrescribed.
Chapter k2. kReview kof kthe kBasic kPrinciples kof
kPharmacology kMultiple kChoice
Identify kthe kchoice kthat kbest kcompletes kthe kstatement kor kanswers kthe kquestion.
k 1. kA kpatient’s knutritional kintake kand klaboratory kresults kreflect khypoalbuminemia. kThis kis
kcritical kto kprescribing kbecause:
1. Distribution kof kdrugs kto ktarget ktissue kmay kbe kaffected.
2. The ksolubility kof kthe kdrug kwill knot kmatch kthe ksite kof kabsorption.
3. There kwill kbe kless kfree kdrug kavailable kto kgenerate kan keffect.
4. Drugs kbound kto kalbumin kare kreadily kexcreted kby kthe kkidneys.
k 2. kDrugs kthat khave ka ksignificant kfirst-pass k effect:
1. Must kbe kgiven kby kthe kenteral k(oral) kroute konly
2. Bypass kthe khepatic kcirculation
3. Are krapidly kmetabolized kby kthe kliver kand kmay khave klittle kif kany kdesired kaction
4. Are kconverted kby kthe kliver kto kmore kactive kand kfat-soluble kforms
k 3. kThe kroute kof k excretion kof ka kvolatile kdrug kwill klikely kbe k the:
1. Kidneys
2. Lungs
3. Bile kand kfeces
4. Skin
k 4. kMedroxyprogesterone k(Depo kProvera) kis kprescribed kintramuscularly k(IM) kto kcreate ka
kstorage kreservoir kof kthe kdrug. kStorage kreservoirs:
1. Assure kthat kthe kdrug kwill kreach kits kintended ktarget ktissue
2. Are kthe kreason kfor kgiving kloading kdoses
3. Increase kthe klength kof ktime ka kdrug kis kavailable kand kactive
4. Are kmost kcommon kin kcollagen ktissues
k 5. kThe kNP kchooses kto kgive kcephalexin kevery k8 khours k based kon kknowledge kof kthe k drug’s:
1. Propensity kto kgo kto kthe ktarget kreceptor
2. Biological khalf-life
3. Pharmacodynamics
4. Safety kand kside keffects
k 6. kAzithromycin kdosing krequires kthat kthe kfirst kday’s kdosage kbe ktwice kthose kof kthe kother k4
kdays kof kthe kprescription. kThis kis kconsidered ka kloading kdose. kA kloading kdose:
1. Rapidly kachieves kdrug klevels kin kthe ktherapeutic krange
2. Requires kfour- kto kfive-half-lives kto kattain
, Pharmacotherapeutics for Advanced Practice Nurse Prescribers, 5th edition Woo
Robinson Test Bank
Chapter k1. kThe kRole kof kthe kNurse kPractitioner kas kPrescribed.
3. Is kinfluenced kby krenal kfunction
4. Is kdirectly krelated kto kthe kdrug kcirculating kto kthe ktarget k tissues
k 7. kThe kpoint kin ktime kon kthe kdrug kconcentration kcurve kthat kindicates kthe kfirst ksign kof ka
ktherapeutic keffect kis kthe:
1. Minimum kadverse keffect klevel
2. Peak kof kaction